n-desmethylclobazam has been researched along with Spasms, Infantile in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Leon, J; Diaz, FJ; Spina, E | 1 |
| Albani, F; Baruzzi, A; Contin, M; Parmeggiani, A; Riva, R; Sangiorgi, S | 1 |
1 review(s) available for n-desmethylclobazam and Spasms, Infantile
| Article | Year |
|---|---|
Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.
Topics: Animals; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Clobazam; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Monitoring; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Spasms, Infantile | 2013 |
1 other study(ies) available for n-desmethylclobazam and Spasms, Infantile
| Article | Year |
|---|---|
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam.
Topics: Alleles; Anti-Anxiety Agents; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Child; Cytochrome P-450 CYP2C19; Drug Monitoring; Genotype; Humans; Infant, Newborn; Isoenzymes; Male; Mixed Function Oxygenases; Phenotype; Polymorphism, Genetic; Spasms, Infantile | 2002 |